Esperion Therapeutics
ESPR
#6204
Rank
HK$6.73 B
Marketcap
HK$28.40
Share price
-1.62%
Change (1 day)
48.59%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: HK$6.73 Billion

As of December 2025 Esperion Therapeutics has a market cap of HK$6.73 Billion. This makes Esperion Therapeutics the world's 6204th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$6.73 B93.06%
2024HK$3.48 B31.34%
2023HK$2.65 B-25.96%
2022HK$3.58 B51.06%
2021HK$2.37 B-54.55%
2020HK$5.22 B-59.1%
2019HK$12.77 B32.16%
2018HK$9.66 B-28.3%
2017HK$13.47 B515.44%
2016HK$2.18 B-43.63%
2015HK$3.88 B-39.12%
2014HK$6.38 B290.41%
2013HK$1.63 B

End of Day market cap according to different sources

On Dec 17th, 2025 the market cap of Esperion Therapeutics was reported to be:

HK$6.78 Billion
by Nasdaq info icon info icon
HK$6.73 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
HK$24.93 B 270.28%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$77.43 B 1,050.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.107 T 16,353.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$618.38 B 9,083.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$26.40 B 292.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
HK$3.25 B-51.70%๐Ÿ‡บ๐Ÿ‡ธ USA